Vertebroplasty for the Treatment of Fractures Due to Osteoporosis

Vertebroplasty for the Treatment of Fractures Due to Osteoporosis

This study is currently recruiting patients.
Verified by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) April 2007

Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
ClinicalTrials.gov Identifier: NCT00068822

clinical trials Purpose

Vertebroplasty is a procedure used to stabilize broken vertebrae, the bones that form the spine. This study will evaluate the effectiveness of vertebroplasty for the treatment of fractures due to osteoporosis.
Condition Intervention Phase
Spinal Fractures
Osteoporosis
 Procedure: Percutaneous vertebroplasty
Phase III

MedlinePlus related topics:  Back Injuries;   Osteoporosis

Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study

Official Title: Investigational Vertebroplasty Efficacy and Safety Trial (INVEST)

Further study details as provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):
Primary Outcome Measures: 
  • Back-specific functional status using Roland Scale at the one-month time frame

Secondary Outcome Measures: 
  • Health status outcome using SF-36

Total Enrollment:  294

Spontaneous, atraumatic compression fractures due to osteoporosis occur in more than 700,000 patients per year. Pain associated with these fractures may be excruciating, but before the advent of percutaneous vertebroplasty, treatment options were limited. Analgesic medications, bed rest, and bracing have been the mainstays of treatment, but each of these therapies has substantial limitations.

Because of the dearth of viable treatment options for osteoporotic vertebral compression fractures, the practice of percutaneous vertebroplasty, which involves injection of polymethylmethacrylate (medical cement) into the fractured vertebra, has disseminated rapidly. However, evidence for the efficacy of percutaneous vertebroplasty is currently limited to uncontrolled, nonblinded, small case studies. Even though high rates of success are reported, with up to 90% of patients achieving substantial pain relief, these case studies have not accounted for numerous important potential biases, including the natural tendency for compression fractures to heal spontaneously, regression toward the mean (wherein patients seek medical attention when pain is maximum), and the placebo effect. This study will examine the clinical efficacy of percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures.

Participants in this study will be randomly assigned to receive either percutaneous vertebroplasty or a sham procedure (placebo control group). Participants may have up to 2 spinal levels treated. Participants will be enrolled in the study for 1 year and will have study visits at entry and Months 1 and 12. There will also be phone visits at Days 1, 2, 3, and 14 and Months 3 and 6. After Month 1, crossover from the placebo group to the vertebroplasty group will be allowed.

clinical trials Eligibility

Ages Eligible for Study:  50 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Confirmed osteoporosis or osteopenia
  • Vertebral compression fracture in vertebrae T4 through L5
  • Pain not responsive to medical therapy

Exclusion Criteria:

  • Malignant tumor or spinal canal compromise
  • Local or systemic infection
  • Pregnancy
  • Hip fracture

clinical trials Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00068822


United States, Minnesota
      Mayo Clinic, Rochester,  Minnesota,  55905,  United States; Recruiting
Leigh A. Gray, CCRA  507-255-4377    gray.leigh@mayo.edu 
David F. Kallmes, MD,  Principal Investigator

Study chairs or principal investigators

David F. Kallmes, MD,  Principal Investigator,  Mayo Clinic   

clinical trials More Information

Publications

Kallmes DF, Jensen ME. Percutaneous vertebroplasty. Radiology. 2003 Oct;229(1):27-36. Review.

Study ID Numbers:  R01 AR49373; NIAMS-096
Last Updated:  April 25, 2007
Record first received:  September 10, 2003
ClinicalTrials.gov Identifier:  NCT00068822
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on June 12, 2007
Last Updated: 06/13/2007
What is This?

Related Articles on this Topic